112 related articles for article (PubMed ID: 28193656)
1. Within-Host Selection of Drug Resistance in a Mouse Model Reveals Dose-Dependent Selection of Atovaquone Resistance Mutations.
Nuralitha S; Murdiyarso LS; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AIM; Marzuki S
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193656
[TBL] [Abstract][Full Text] [Related]
2. Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.
Nuralitha S; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AI; Marzuki S
Antimicrob Agents Chemother; 2016 Jan; 60(1):258-63. PubMed ID: 26503662
[TBL] [Abstract][Full Text] [Related]
3. Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection.
Nuralitha S; Siregar JE; Syafruddin D; Hoepelman AIM; Marzuki S
Malar J; 2017 May; 16(1):216. PubMed ID: 28535797
[TBL] [Abstract][Full Text] [Related]
4. Mutation underlying resistance of Plasmodium berghei to atovaquone in the quinone binding domain 2 (Qo(2)) of the cytochrome b gene.
Siregar JE; Syafruddin D; Matsuoka H; Kita K; Marzuki S
Parasitol Int; 2008 Jun; 57(2):229-32. PubMed ID: 18248769
[TBL] [Abstract][Full Text] [Related]
5. Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes.
Goodman CD; Siregar JE; Mollard V; Vega-Rodríguez J; Syafruddin D; Matsuoka H; Matsuzaki M; Toyama T; Sturm A; Cozijnsen A; Jacobs-Lorena M; Kita K; Marzuki S; McFadden GI
Science; 2016 Apr; 352(6283):349-53. PubMed ID: 27081071
[TBL] [Abstract][Full Text] [Related]
6. Menoctone Resistance in Malaria Parasites Is Conferred by M133I Mutations in Cytochrome
Blake LD; Johnson ME; Siegel SV; McQueen A; Iyamu ID; Shaikh AK; Shultis MW; Manetsch R; Kyle DE
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584157
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for the atovaquone action on the Plasmodium cytochrome bc1 complex.
Siregar JE; Kurisu G; Kobayashi T; Matsuzaki M; Sakamoto K; Mi-ichi F; Watanabe Y; Hirai M; Matsuoka H; Syafruddin D; Marzuki S; Kita K
Parasitol Int; 2015 Jun; 64(3):295-300. PubMed ID: 25264100
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the cytochrome b gene of Plasmodium berghei conferring resistance to atovaquone.
Syafruddin D; Siregar JE; Marzuki S
Mol Biochem Parasitol; 1999 Nov; 104(2):185-94. PubMed ID: 10593174
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium chabaudi chabaudi malaria parasites can develop stable resistance to atovaquone with a mutation in the cytochrome b gene.
Afonso A; Neto Z; Castro H; Lopes D; Alves AC; Tomás AM; Rosário VD
Malar J; 2010 May; 9():135. PubMed ID: 20492669
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance.
Berry A; Senescau A; Lelièvre J; Benoit-Vical F; Fabre R; Marchou B; Magnaval JF
Trans R Soc Trop Med Hyg; 2006 Oct; 100(10):986-8. PubMed ID: 16690094
[TBL] [Abstract][Full Text] [Related]
11. Long-acting injectable atovaquone nanomedicines for malaria prophylaxis.
Bakshi RP; Tatham LM; Savage AC; Tripathi AK; Mlambo G; Ippolito MM; Nenortas E; Rannard SP; Owen A; Shapiro TA
Nat Commun; 2018 Jan; 9(1):315. PubMed ID: 29358624
[TBL] [Abstract][Full Text] [Related]
12. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations.
Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J
Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361
[TBL] [Abstract][Full Text] [Related]
13. Detection of atovaquone-proguanil resistance conferring mutations in Plasmodium falciparum cytochrome b gene in Luanda, Angola.
Pimentel S; Nogueira F; Benchimol C; Quinhentos V; Bom J; Varandas L; do Rosário V; Bernardino L
Malar J; 2006 Apr; 5():30. PubMed ID: 16597338
[TBL] [Abstract][Full Text] [Related]
14. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites.
Srivastava IK; Morrisey JM; Darrouzet E; Daldal F; Vaidya AB
Mol Microbiol; 1999 Aug; 33(4):704-11. PubMed ID: 10447880
[TBL] [Abstract][Full Text] [Related]
15. Advanced Molecular Detection of Malarone Resistance.
Talundzic E; Plucinski MM; Biliya S; Silva-Flannery LM; Arguin PM; Halsey ES; Barnwell JW; Vannberg F; Udhayakumar V
Antimicrob Agents Chemother; 2016 Jun; 60(6):3821-3. PubMed ID: 27001821
[TBL] [Abstract][Full Text] [Related]
16. Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT; Gbotosho GO; Folarin OA; Milner D; Sarr O; Sowunmi A; Kyle DE; Milhous WK; Wirth DF; Oduola AM
Malar J; 2006 Oct; 5():82. PubMed ID: 17020611
[TBL] [Abstract][Full Text] [Related]
17. Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment.
Musset L; Le Bras J; Clain J
Mol Biol Evol; 2007 Aug; 24(8):1582-5. PubMed ID: 17488741
[TBL] [Abstract][Full Text] [Related]
18. Analyses of cytochrome b mutations in Plasmodium falciparum isolates in Thai-Myanmar border.
Naoshima-Ishibashi Y; Iwagami M; Kawazu S; Looareesuwan S; Kano S
Travel Med Infect Dis; 2007 Mar; 5(2):132-4. PubMed ID: 17298921
[TBL] [Abstract][Full Text] [Related]
19. Malarone treatment failure not associated with previously described mutations in the cytochrome b gene.
Wichmann O; Muehlen M; Gruss H; Mockenhaupt FP; Suttorp N; Jelinek T
Malar J; 2004 Jun; 3():14. PubMed ID: 15186499
[TBL] [Abstract][Full Text] [Related]
20. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
Kuhn S; Gill MJ; Kain KC
Am J Trop Med Hyg; 2005 Apr; 72(4):407-9. PubMed ID: 15827276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
